文献速递类风湿关节炎

基于SDAI和CDAI的类风湿关节炎 flare 定义

Definition of rheumatoid arthritis flare based on SDAI and CDAI.
PubMed 文献 · Ann Rheum Dis · 2024-01-11

研究基于挪威NOR-DMARD登记和维也纳RA队列,通过ROC分析确定SDAI和CDAI绝对变化量的flare定义:分别增加4.7和4.5。该定义在测试队列和外部验证队列中表现良好,flare显著影响功能和结构结局,反映疾病核心指标一致恶化。

要点

  • SDAI绝对变化增加4.7定义为flare,CDAI绝对变化增加4.5定义为flare。
  • 定义在NOR-DMARD测试队列和维也纳外部验证队列中表现良好。
  • flare显著影响功能(HAQ变化+0.43)和结构(改良Sharp评分高43%)结局。

核心结论

  • 研究提供了基于SDAI和CDAI的RA flare新定义,并在两个大型独立真实世界队列中验证。

研究设计与样本

  • 分析挪威抗风湿药登记(NOR-DMARD)和维也纳RA队列的治疗疗程,NOR-DMARD按80%训练队列和20%测试队列分割,定义在维也纳队列外部验证。

主要发现

  • 分析NOR-DMARD的4256个治疗疗程和维也纳RA队列的2557个治疗疗程。
  • SDAI和CDAI绝对变化量的初步flare定义分别为增加4.7和4.5。
  • flare显著影响功能结局(∆ Health Assessment Questionnaire flare vs no-flare +0.43;p<0.001)。
  • flare后结构结局∆ modified Sharp Score高43%(p<0.001)。

关键数值与推荐

  • SDAI绝对变化增加4.7定义为flare。
  • CDAI绝对变化增加4.5定义为flare。

临床怎么用

  • 作者认为这些定义可用于指导临床实践决策和设计临床试验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop and validate definitions for disease flares in rheumatoid arthritis (RA) based on the quantitative Simplified and Clinical Disease Activity Indices (SDAI, CDAI). METHODS: We analysed RA treatment courses from the Norwegian disease-modifying antirheumatic drug registry (NOR-DMARD) and the Vienna RA cohort. In a receiver operating curve analysis, we determined flare definitions for absolute changes in SDAI and CDAI based on a semiquantitative patient anchor. NOR-DMARD was sampled into an 80%-training cohort for cut point derivation and a 20%-test cohort for internal validation. The definitions were then externally validated in the independent Vienna RA cohort and tested regarding their performance on longitudinal, content, face, and construct validity. RESULTS: We analysed 4256 treatment courses from NOR-DMARD and 2557 from the Vienna RA cohort. The preliminary definitions for absolute changes in SDAI and CDAI for flare are an increase of 4.7 and 4.5, respectively. The definitions performed well in the test and external validation cohorts, and showed clinical face and construct validity, as flares significantly impact both functional ( ∆ Health Assessment Questionnaire flare vs no-flare +0.43; p<0.001) and structural ( ∆ modified Sharp Score 43% higher after flare; p<0.001) disease outcomes, and reflect consistent worsening across all disease core sets, both patient reported and objective. CONCLUSION: We here provide novel definitions for flare in RA based on SDAI and CDAI, validated in two large independent real-world cohorts. In times of highly effective medications for RA, and consideration of their tapering, these definitions will be useful for guiding decision making in clinical practice and designing clinical trials.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Konzett V, Kerschbaumer A, Smolen JS, et al. Definition of rheumatoid arthritis flare based on SDAI and CDAI. Ann Rheum Dis. 2024. PMID: 37890977. doi:10.1136/ard-2023-224742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。